A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine
Azosemide
The risk or severity of adverse effects can be increased when Azosemide is combined with Choline salicylate.
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine
Piretanide
The risk or severity of adverse effects can be increased when Piretanide is combined with Choline salicylate.
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine
Cilazaprilat
The risk or severity of renal failure can be increased when Choline salicylate is combined with Cilazaprilat.
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine
Quinoline Yellow WS
The risk or severity of renal failure can be increased when Choline salicylate is combined with Quinoline Yellow WS.
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine
Quinaprilat
The risk or severity of renal failure can be increased when Choline salicylate is combined with Quinaprilat.
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine
Perindoprilat
The risk or severity of renal failure can be increased when Choline salicylate is combined with Perindoprilat.
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine
Moexiprilat
The risk or severity of renal failure can be increased when Choline salicylate is combined with Moexiprilat.
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine
Trandolaprilat
The risk or severity of renal failure can be increased when Choline salicylate is combined with Trandolaprilat.
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine
Ramiprilat
The risk or severity of renal failure can be increased when Choline salicylate is combined with Ramiprilat.
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine
Fosinoprilat
The risk or severity of renal failure can be increased when Choline salicylate is combined with Fosinoprilat.
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine
Benazeprilat
The risk or severity of renal failure can be increased when Choline salicylate is combined with Benazeprilat.
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine
Delapril
The risk or severity of renal failure can be increased when Choline salicylate is combined with Delapril.
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine
Zofenopril
The risk or severity of renal failure can be increased when Choline salicylate is combined with Zofenopril.
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine
Imidapril
The risk or severity of renal failure can be increased when Choline salicylate is combined with Imidapril.
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine
Enalaprilat
The risk or severity of renal failure can be increased when Choline salicylate is combined with Enalaprilat.
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine
Gastric inhibitory polypeptide
Choline salicylate may increase the hypoglycemic activities of Gastric inhibitory polypeptide.
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine
Tirzepatide
Choline salicylate may increase the hypoglycemic activities of Tirzepatide.
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine
Englitazone
Choline salicylate may increase the hypoglycemic activities of Englitazone.
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine
Taspoglutide
Choline salicylate may increase the hypoglycemic activities of Taspoglutide.
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine
Semaglutide
Choline salicylate may increase the hypoglycemic activities of Semaglutide.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3